I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk provides mergers and acquisitions (M&A) advisory to clients across the healthcare industry, with a focus in the healthcare services, medical technology, diagnostics, specialty pharmaceuticals and digital health sectors. He has executed sell-side and buy-side M&A transactions for private equity clients, publicly-traded companies and privately-held and family-owned businesses.
Through a hands-on style of processing deals, Dirk develops long-term relationships and provides tailored solutions for each client, addressing individual needs and overcoming complex situations.
Prior to joining Lincoln International, Dirk was a Managing Director at Raymond James, where he led the Frankfurt office and built out its European healthcare activities. Previously, he was a partner at Richmond Park Partners and head of M&A at Berenberg as one of the most senior investment bankers.
Dirk graduated from Mannheim University and Copenhagen Business School with a Diplom-Kaufmann, equivalent to master’s in business administration.
Recent Transactions in Healthcare
Lincoln International is pleased to announce that it has advised The Vet Connection on its sale to Pets at Home Group PLC (LSE:PETS)
Lincoln International is pleased to announce that LT Smile Corporation (Benevis) has been acquired under Section 363 of the United States Bankruptcy Code by New Mountain Capital
Lincoln International is pleased to announce that it served as the exclusive financial advisor to Alva-Amco Pharmacal in its sale to Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Lincoln International is pleased to announce that Choice Health Insurance, LLC, a fully integrated consumer acquisition platform specializing in the high-growth, Medicare Advantage marketplace, has been acquired by Alight Solutions, a portfolio company of Blackstone
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ) has received an investment from Abry Partners LP
Lincoln International advised Gruppo Sapio on the acquisition of a majority stake in Homeperf from Parquest Capital; BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Perspectives by Dirk-Oliver Löffler
Q&A with Lincoln’s Newest Healthcare Managing Directors: Unpacking Market Dynamics & Deal-making for the Months Ahead
In summer 2020, Lincoln International welcomed three healthcare Managing Directors – Dirk-Oliver Löffler, in Germany, Roddy O’Neill, in New York, and Emily Wildes, in Chicago. Their arrival complements a global team of […]